MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 214 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,172,820 | -22.2% | 10,217,282 | -3.2% | 0.00% | 0.0% |
| Q2 2023 | $131,247,960 | -11.3% | 10,558,967 | -0.0% | 0.00% | -25.0% |
| Q1 2023 | $147,934,350 | -0.5% | 10,559,197 | +1.6% | 0.00% | 0.0% |
| Q4 2022 | $148,680,599 | -43.0% | 10,389,979 | +1.7% | 0.00% | -50.0% |
| Q3 2022 | $260,728,000 | -12.0% | 10,212,598 | -2.1% | 0.01% | 0.0% |
| Q2 2022 | $296,402,000 | -20.1% | 10,433,033 | -0.8% | 0.01% | -11.1% |
| Q1 2022 | $370,766,000 | -16.0% | 10,512,217 | -0.2% | 0.01% | -10.0% |
| Q4 2021 | $441,359,000 | -11.0% | 10,533,609 | +4.2% | 0.01% | -16.7% |
| Q3 2021 | $496,048,000 | +42.4% | 10,106,939 | +21.1% | 0.01% | +33.3% |
| Q2 2021 | $348,393,000 | +82.5% | 8,348,750 | +55.9% | 0.01% | +80.0% |
| Q1 2021 | $190,908,000 | +44.4% | 5,356,554 | +13.6% | 0.01% | +25.0% |
| Q4 2020 | $132,212,000 | – | 4,713,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |